Aosta Valley registry maps animal cancer burden across species: full analysis
Aosta Valley’s new animal cancer registry report offers a practical example of what veterinary cancer surveillance can look like at the regional level. The project, published in Veterinary Record Open, tracked tumors diagnosed in livestock, pets, and wildlife from January 2004 through May 2024 and found distinct cancer patterns across species, while also showing that a registry can be sustained through collaboration between field veterinarians, diagnosticians, and epidemiologists. (researchgate.net)
That matters because veterinary cancer registries remain relatively rare, and many past efforts have struggled with fragmented reporting, uneven participation, and limited population data. A longstanding review of companion-animal cancer registries concluded that differences in inclusion criteria, collection methods, and reference populations have made comparisons difficult, even though registries can reveal geographic, breed, genetic, and environmental risk patterns. Global standardization efforts are still underway through groups such as the Global Initiative for Veterinary Cancer Surveillance, which is working to align reporting methods and coding systems across registries. (pubmed.ncbi.nlm.nih.gov)
In Aosta Valley, investigators identified 1,268 total tumor cases over the study period. Pets accounted for the vast majority, at 91% of cases, followed by farm animals at 8% and wildlife at 1%. Among livestock, liver tumors, especially hepatocellular carcinoma, and eye tumors, especially squamous cell carcinoma, were the most frequent findings. In pets, skin tumors were the leading category in both dogs and cats, and mammary gland tumors were especially common in dogs. The report’s authors also highlighted operational limitations, including incomplete case ascertainment in livestock and wildlife, and denominator challenges in pets. (researchgate.net)
Additional background from the project report suggests those limitations were tied to the realities of veterinary data collection. Only 11 of 16 veterinary facilities listed in the regional companion-animal database contributed data, according to the report, and many historical cases lacked basic information such as sex, age, tumor site, or animal identification. The report also noted limited use of a digital reporting form for new cases. Those details help explain why the registry is best understood as a proof of feasibility first, and a fully mature surveillance system second. (researchgate.net)
The broader field gives that effort added relevance. Reviews of comparative oncology have emphasized that dogs and cats can serve as useful sentinels for shared environmental exposures and as models for naturally occurring cancer, especially when data are collected systematically over time. More recent literature has also pointed to structured veterinary registries as a way to strengthen One Health research by linking species-specific cancer patterns with environmental, genetic, and population-level trends. (pubmed.ncbi.nlm.nih.gov)
Why it matters: For practicing veterinarians, pathology labs, and public health teams, the Aosta Valley registry is less about a single headline number and more about infrastructure. If regional registries become more standardized and complete, they could support better benchmarking of tumor burden, improve recognition of locally common cancers, and help identify emerging environmental or husbandry-related signals. For companion-animal practice, that could eventually translate into stronger client communication with pet parents about screening, diagnostics, and referral patterns. For food-animal and wildlife health, it may also open a path to better understanding cancers that are currently underdetected or inconsistently recorded. (researchgate.net)
What to watch: The next phase is likely to focus on participation and standardization: getting more clinics to report, improving data completeness at the time of diagnosis, and aligning coding with broader veterinary surveillance frameworks. If that happens, Aosta Valley could become a more useful comparator for other Italian and European registries, and a stronger platform for comparative oncology research across animal and human health. That last point is an inference based on the registry’s stated goals and the direction of international standardization efforts, rather than a declared timeline from the authors. (researchgate.net)